NO20002968L - Nye uretaner, tio og ditioanaloger, salter derav, medikamenter inneholdende nevnte forbindelser og anvendelse og fremgangsmÕte for fremstilling derav - Google Patents

Nye uretaner, tio og ditioanaloger, salter derav, medikamenter inneholdende nevnte forbindelser og anvendelse og fremgangsmÕte for fremstilling derav

Info

Publication number
NO20002968L
NO20002968L NO20002968A NO20002968A NO20002968L NO 20002968 L NO20002968 L NO 20002968L NO 20002968 A NO20002968 A NO 20002968A NO 20002968 A NO20002968 A NO 20002968A NO 20002968 L NO20002968 L NO 20002968L
Authority
NO
Norway
Prior art keywords
thio
preparation
salts
compounds
medicaments containing
Prior art date
Application number
NO20002968A
Other languages
English (en)
Other versions
NO20002968D0 (no
Inventor
Roland Maier
Peter Mueller
Gebhard Adelgoss
Gebhard Schilcher
Rudolf Hurnaus
Michael Mark
Bernhard Eisele
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20002968D0 publication Critical patent/NO20002968D0/no
Publication of NO20002968L publication Critical patent/NO20002968L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/56—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02—Monothiocarbamic acids; Derivatives thereof
    • C07C333/06—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/14—Dithiocarbamic acids; Derivatives thereof
    • C07C333/18—Esters of dithiocarbamic acids
    • C07C333/24—Esters of dithiocarbamic acids having nitrogen atoms of dithiocarbamate groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Det er beskrevet uretaner og tio og ditioanaloger ifølge generell formel (I), hvori m, n, A, X, Y og R1-R8 er som definert i krav 1. Det er videre beskrevet entaniomerer, diastereomerer og salter derav, spesielt fysiologisk akseptable syreadditive salter med verdifulle egenskaper som utviser en inhiberende effekt på kolesterolbiosyntesen, i tillegg til medikamenter inneholdende nevnte forbindelse, anvendelse derav og en fremgangsmåte for fremstilling derav.
NO20002968A 1997-12-10 2000-06-09 Nye uretaner, tio og ditioanaloger, salter derav, medikamenter inneholdende nevnte forbindelser og anvendelse og fremgangsmÕte for fremstilling derav NO20002968L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754795A DE19754795A1 (de) 1997-12-10 1997-12-10 Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
PCT/EP1998/007962 WO1999029662A2 (de) 1997-12-10 1998-12-08 Urethane, ihre thio- und dithioanaloga, deren salze, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
NO20002968D0 NO20002968D0 (no) 2000-06-09
NO20002968L true NO20002968L (no) 2000-08-09

Family

ID=7851380

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002968A NO20002968L (no) 1997-12-10 2000-06-09 Nye uretaner, tio og ditioanaloger, salter derav, medikamenter inneholdende nevnte forbindelser og anvendelse og fremgangsmÕte for fremstilling derav

Country Status (30)

Country Link
US (1) US6346545B1 (no)
EP (1) EP1045832B1 (no)
JP (1) JP4001317B2 (no)
KR (1) KR20010024708A (no)
CN (1) CN1281431A (no)
AR (1) AR014405A1 (no)
AT (1) ATE291570T1 (no)
AU (1) AU747173B2 (no)
BG (1) BG104501A (no)
BR (1) BR9813545A (no)
CA (1) CA2310055C (no)
CO (1) CO5290251A1 (no)
CZ (1) CZ20002150A3 (no)
DE (2) DE19754795A1 (no)
EA (1) EA003298B1 (no)
EE (1) EE200000340A (no)
HR (1) HRP980621A2 (no)
HU (1) HUP0100292A3 (no)
ID (1) ID21432A (no)
IL (1) IL135737A0 (no)
NO (1) NO20002968L (no)
NZ (1) NZ505594A (no)
PE (1) PE133599A1 (no)
PL (1) PL341654A1 (no)
SK (1) SK8602000A3 (no)
TR (1) TR200001636T2 (no)
UY (1) UY25288A1 (no)
WO (1) WO1999029662A2 (no)
YU (1) YU35500A (no)
ZA (1) ZA9811263B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009216678B2 (en) * 2008-02-22 2013-11-21 Basf Se Fungicidal compositions comprising 3'-bromine-2,3,4,6'-tetramethoxy-2'-6-dimethylbenzophenone
CN103596570B (zh) * 2010-12-27 2018-02-16 密苏里大学管委会 作为抗癌治疗的蛋白质靶的氧化鲨烯环化酶

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2025490C (en) * 1989-09-22 2003-09-16 James R. Mccarthy Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
US5011859A (en) * 1990-03-30 1991-04-30 Merrell Dow Pharmaceuticals Inc. Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase
CA2047375C (en) * 1990-07-25 2003-04-15 Charlotte L. Barney Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
US5084461A (en) * 1991-03-27 1992-01-28 Merrell Dow Pharmaceuticals Inc. Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis
DE4303840A1 (de) * 1992-10-22 1994-08-11 Thomae Gmbh Dr K Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US5466687A (en) 1992-10-22 1995-11-14 Dr. Karl Thomae Gmbh Arylidene-1-azacycloalkanes and arylalkyl-1-azacyclo-alkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
DE4239150A1 (de) * 1992-11-20 1994-05-26 Thomae Gmbh Dr K O-Acyl-4-phenyl-cyclohexanole, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4239151A1 (de) * 1992-11-20 1994-05-26 Thomae Gmbh Dr K N,N-Disubstituierte Arylcycloalkylamine, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4438020A1 (de) * 1994-10-25 1996-05-02 Thomae Gmbh Dr K N-substituierte Arylcyclohexylacylamine, ihre Salze mit physiologisch verträglichen organischen oder anorganischen Säuren, Verfahren zur Herstellung dieser Verbindungen und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
CN1281431A (zh) 2001-01-24
EP1045832A2 (de) 2000-10-25
YU35500A (sh) 2002-09-19
NO20002968D0 (no) 2000-06-09
DE19754795A1 (de) 1999-06-17
CA2310055A1 (en) 1999-06-17
WO1999029662A2 (de) 1999-06-17
BR9813545A (pt) 2000-10-10
HRP980621A2 (en) 1999-08-31
TR200001636T2 (tr) 2001-08-21
US6346545B1 (en) 2002-02-12
AU1759399A (en) 1999-06-28
JP2001525393A (ja) 2001-12-11
EE200000340A (et) 2001-08-15
IL135737A0 (en) 2001-05-20
ATE291570T1 (de) 2005-04-15
CZ20002150A3 (cs) 2001-11-14
ID21432A (id) 1999-06-10
US20020019536A1 (en) 2002-02-14
JP4001317B2 (ja) 2007-10-31
BG104501A (bg) 2001-03-30
PL341654A1 (en) 2001-04-23
PE133599A1 (es) 2000-01-13
ZA9811263B (en) 2000-06-09
DE59812686D1 (de) 2005-04-28
AU747173B2 (en) 2002-05-09
SK8602000A3 (en) 2000-11-07
HUP0100292A3 (en) 2002-11-28
CO5290251A1 (es) 2003-06-27
AR014405A1 (es) 2001-02-28
NZ505594A (en) 2001-11-30
UY25288A1 (es) 2000-12-29
EA003298B1 (ru) 2003-04-24
CA2310055C (en) 2008-09-23
WO1999029662A3 (de) 1999-08-19
KR20010024708A (ko) 2001-03-26
HUP0100292A2 (hu) 2001-07-30
EP1045832B1 (de) 2005-03-23
EA200000633A1 (ru) 2000-12-25

Similar Documents

Publication Publication Date Title
RU2196769C2 (ru) Производные аминобензойной кислоты, фармацевтическая композиция
DE69904302D1 (de) Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung
DK0928609T3 (da) Farmaceutiske præparater indeholdende sulfamatderivater som steroidsulfatase-inhibitorer
NO20005715L (no) Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
DK0763524T3 (da) Hidtil ukendte urinstofderivater, der har ACAT-inhiberende aktivitet, deres fremstilling og deres terapeutiske profylaktisk
NO963370L (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
CA2336412A1 (en) Medicament for treatment of diabetes
AU591860B2 (en) Pyrolidineamide derivative having anti-prolyl endopeptidase
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
NO20040881L (no) Orale antidiabetes midler.
NO20052683L (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
AU624951B2 (en) New sulfonamides derived from benzocyclic or benzoheterocyclic acids, their preparation and application in thereapeutics
NO973652L (no) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreseptor-antagonist
NO20050087L (no) N-benzoylureido-kanelsyrederivater, fremgangsmate for fremstilling og anvendelse av disse
DE69828284D1 (de) Naphthyridinderivate oder salze davon
NO981393L (no) Guanidinoproteasehemmere
NO963655L (no) Nye aminosyrederivater, fremgangsmåte for fremstilling av dem og farmasöytiske blandinger som inneholder dem
NO20023001L (no) Substituerte piperazinderivater som MTP inhibitorer
CA2191850A1 (en) Cancerous metastasis inhibitor
NO20002968L (no) Nye uretaner, tio og ditioanaloger, salter derav, medikamenter inneholdende nevnte forbindelser og anvendelse og fremgangsmÕte for fremstilling derav
NO943210L (no) Laktolderivater, deres fremstilling og anvendelse
AU7624398A (en) New substituted tetrahydropyridine compounds, process for preparing them and pharmaceutical compositions containing them
NO975402L (no) Nye benzopyran forbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem
EP1174421A4 (en) 3-AMIDINOBENZENESULFONAMIDE DERIVATIVES, MEDICAL PREPARATIONS CONTAINING IT AND INTERMEDIATE PRODUCTS IN THEIR PRODUCTION
MX9800705A (es) Compuestos heterociclicos, composiciones para tratar isquemia de miocardio que los contiene, y procedimiento para su preparacion.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application